Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p16INK4a can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer. Overlapping reading frames in the INK4A/ARF gene encode p16INK4a and a distinct tumour-suppressor protein, p19ARF (ref. 3). Here we describe the generation and characterization of a p16Ink4a-specific knockout mouse that retains normal p19Arf function. Mice lacking p16Ink4a were born with the expected mendelian distribution and exhibited normal development except for thymic hyperplasia. T cells deficient in p16Ink4a exhibited enhanced mitogenic responsiveness, consistent with the established role of p16Ink4a in constraining cellular proliferation. In contrast to mouse embryo fibroblasts (MEFs) deficient in p19Arf (ref. 4), p16Ink4a-null MEFs possessed normal growth characteristics and remained susceptible to Ras-induced senescence. Compared with wild-type MEFs, p16Ink4a-null MEFs exhibited an increased rate of immortalization, although this rate was less than that observed previously for cells null for Ink4a/Arf, p19Arf or p53 (refs 4, 5). Furthermore, p16Ink4a deficiency was associated with an increased incidence of spontaneous and carcinogen-induced cancers. These data establish that p16Ink4a, along with p19Arf, functions as a tumour suppressor in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p19 Arf and, to a lesser extent, p16 Ink4a have been shown to play a role in the activation of cellular senescence and immortalization on passaging of primary mouse cells in culture (26, 43, 44).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [43]
In the citing paper
“In vivo (mouse model) studies indicate that p16 suppresses the development of spontaneous cancer (Sharpless et al., 2001).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Sharpless et al., 2001
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Real-time methylation-specific PCR (MSR) was used to detect the methylation of CpG islands flanking the translation start site of murine p16Ink4a 28,29, revealing a significant increase in methylated CpG sites at the promoter region of p16Ink4a in middle-aged mouse tissues after TAC treatment compared with vehicle controls (Figure 3H).”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [28]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“exhibit more rapid growth rates and are more readily immortalized in culture, are susceptible to transformation by activated H-Ras alone, and exhibit resistance to Ras-induced senescenc”
BackgroundRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Mice heterozygous for this mutant allele were crossed with EIIa-Cre mic”
MethodD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · cited 1×
“Accumulation of p16 INK4a correlates with the onset of senescence in human cell”
Background
Cited by
Items 601–700 of 850
Senescence and Senescence-Related Disorders
Wang, Z. P., & Inuzuka, H. (2013) · InTech eBooks · doi:10.5772/56158 · Cited by 12
Molecular biology and genetic models of glioma and medulloblastoma
Lassman, A. B., & Holland, E. C. (2006) · CRC Press eBooks · doi:10.1201/b13439-70 · Cited by 11
Role of the E2F1-p19ARF-p53 Pathway in Ischemic Acute Renal Failure
Tanaka, H., Terada, Y., Okado, T., Inoshita, S., Kuwahara, M., & Sasaki, S. (2005) · Nephron Physiology · doi:10.1159/000086642 · Cited by 11
Molecular cloning and characterization of the human p19INK4d gene promoter
Matsuzaki, Y., Miyazawa, K., Yokota, T., Hitomi, T., Yamagishi, H., & Sakai, T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02647-9 · Cited by 11
Roca, R., Kypta, R. M., & Vivanco, M. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0634912100 · Cited by 12
Senescence and Cell Cycle Control
Kiyokawa, H. (2006) · Springer eBooks · doi:10.1007/400_001 · Cited by 12
The INK4a/ARF Locus and Human Cancer
Enders, G. H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:197 · Cited by 14
Sharpless, N. E. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.33.pe24 · Cited by 14
Self-citationChan, W. L., Bucher, C. H., Goldes, J., Ma, A. C., Steiner, M., Willie, B. M., Mundlos, S., & Kornak, U. (2024) · Aging Cell · doi:10.1111/acel.14322 · Cited by 10
Zhao, S., Cui, H., Fang, X., Xia, W., Tao, C., & Li, J. (2024) · BMC Genomics · doi:10.1186/s12864-024-10957-0 · Cited by 14
Oval cell proliferation in p16INK4a expressing mouse liver is triggered by chronic growth stimuli
Ueberham, E., Lindner, R., Kamprad, M., Hiemann, R., Hilger, N., Woithe, B., Mahn, D., Cross, M. A., Sack, U., Gebhardt, R., et al. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00178.x · Cited by 11
Weebadda, W. K. C., Jackson, T. J., & Lin, A. W. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20372 · Cited by 9
An INKlination for epigenetic control of senescence
Peters, G. G. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1108-1133 · Cited by 12
Expression of TBX3 in Hepatocellular Carcinoma and Its Clinical Implication
Li, Z., Wang, Y., Duan, S., Shi, Y., Li, S., Zhang, X., & Ren, J. (2018) · Medical Science Monitor · doi:10.12659/msm.909378 · Cited by 11
Targeting mitochondrial dysfunction to salvage cellular senescence for managing neurodegeneration
Sharma, K., Sarkar, J., Trisal, A., Ghosh, R., Dixit, A., & Singh, A. K. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.016 · Cited by 8
A Dual Role of the Senescence Marker P16Ink4a in Liver Endothelial Cell Function
Wagner, K., Safwan‐Zaiter, H., & Wagner, N. (2024) · Cells · doi:10.3390/cells13231929 · Cited by 10
Adamović, T., Hamta, A., Roshani, L., Lü, X., Röhme, D., Helou, K., Klinga‐Levan, K., & Levan, G. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.02.016 · Cited by 8
The INK4A/Arf Network — Cell Cycle Checkpoint or Emergency Brake?
del Arroyo, A. G., & Peters, G. G. (2005) · Advances in experimental medicine and biology · doi:10.1007/1-4020-3764-3_8 · Cited by 10
p16 Ink4a Interferes with Abelson Virus Transformation by Enhancing Apoptosis
Sachs, Z., Sharpless, N. E., DePinho, R. A., & Rosenberg, N. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3304-3311.2004 · Cited by 8
Self-citationResistance Mechanisms to Cyclin-Dependent Kinase Inhibitors
Wiedemeyer, W. R. (2018) · Resistance to Targeted Anti-Cancer Therapeutics · doi:10.1007/978-3-319-67932-7_8 · Cited by 7
Bennett, D. C. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13163 · Cited by 8
Aktary, Z., McMahon, M., & Larue, L. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_32-1 · Cited by 9
Mouse Models of Inherited Cancer Syndromes
Jahid, S., & Lipkin, S. M. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.011 · Cited by 7
Sustained p16INK4a expression is required to prevent IR-induced tumorigenesis in mice
Palacio, L., Krishnan, V., Le, N. L. O., Sharpless, N. E., & Beausejour, C. M. (2016) · Oncogene · doi:10.1038/onc.2016.298 · Cited by 9
Self-citationBolden, J. E., & Lowe, S. W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00015-9 · Cited by 9
INK4a‐ARF mutations in skin carcinomas from UV irradiated hairless mice
Soufir, N., Queillé, S., Mollier, K., Roux, E., Sarasin, A. R., de Gruijl, F. R., Fourtanier, A. M., Daya–Grosjean, L., & Basset‐Séguin, N. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20004 · Cited by 8
Cosgrove, D., Park, B. H., & Vogelstein, B. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm005 · Cited by 8
Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
Wong, K. M., King, D. A., Schwartz, E. K., Herrera, R. E., & Morrison, A. J. (2022) · Life Science Alliance · doi:10.26508/lsa.202101134 · Cited by 8
Regulation of the Cell Cycle and Interventional Developmental Therapeutics
Ivanchuk, S. M., & Rutka, J. T. (2006) · Elsevier eBooks · doi:10.1016/b978-012088410-0/50047-0 · Cited by 6
Francis, S. M., Chakrabarti, S., & Dick, F. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016434 · Cited by 6
Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis
Nilsson, L. M., Keller, U. B., Yang, C., Nilsson, J. A., Cleveland, J. L., & Roussel, M. F. (2006) · Oncogene · doi:10.1038/sj.onc.1210104 · Cited by 8
Chen, Y., Gu, L., & Deng, D. (2014) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2014.04.012 · Cited by 6
Wang, Y.-J., Chang, H., Kuo, Y.-C., Wang, C., Siao, S.-H., Chang, L. W., & Lin, P. (2010) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2010.11.082 · Cited by 7
Ueberham, E., Glöckner, P., Göhler, C., Straub, B. K., Teupser, D., Schönig, K., Braeuning, A., Höhn, A. K., Jerchow, B., Birchmeier, W., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0278-t · Cited by 6
Dependence of p53-deficient cells on the DHX9 DExH-box helicase
Lee, T., & Pelletier, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15889 · Cited by 6
The Retinoblastoma Protein in Osteosarcomagenesis
Kong, E., & Wong, P. (2012) · InTech eBooks · doi:10.5772/32559 · Cited by 6
p16Ink4a and p19Arf: terrible twins
Weitzman, J. B. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02190-6 · Cited by 6
Modeling Cell Cycle Control and Cancer with pRB Tumor Suppressor
Yamasaki, L. (2006) · Springer eBooks · doi:10.1007/b136682 · Cited by 7
Akt Signaling Accelerates Tumor Recurrence Following Ras Inhibition in the Context of Ink4a/Arf Loss
Robinson, G. L., Robinson, J. P., Lastwika, K. J., Holmen, S. L., & VanBrocklin, M. W. (2013) · Genes & Cancer · doi:10.1177/1947601913513268 · Cited by 5
Sun, L. D., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2022) · Biological Procedures Online · doi:10.1186/s12575-022-00187-7 · Cited by 5
Rodent models of tumours of the central nervous system
Brandner, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13729 · Cited by 5
Vinpocetine Effect on the Juncture of Diabetes and Aging: An in-vitro study
Moeini‐Nodeh, S., Rahimifard, M., Baeeri, M., Hodjat, M., Haghi‐Aminjan, H., & Abdollahi, M. R. (2021) · Drug Research · doi:10.1055/a-1381-6625 · Cited by 5
Immortalized murine tenocyte cells: a novel and innovative tool for tendon research
Oreff, G. L., Maurer, B., ELKhamary, A. N., Ribitsch, I., Sexl, V., & Jenner, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-28318-4 · Cited by 5
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
Genetically Modified Animal Models
Chaible, L. M., Kinoshita, D., Corat, M. A. F., & Dagli, M. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00027-9 · Cited by 7
The Role of Systemic Filtrating Organs in Aging and Their Potential in Rejuvenation Strategies
Kassab, A., Rizk, N. M., & Prakash, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084338 · Cited by 5
Exploring cellular senescence as a tumor suppressor mechanism
Carnero, A., Blanco‐Aparicio, C., Blanco, F., Castro, M. E., Guijarro, M. V., Fominaya, J. M., Link, W., Martínez, J. F., Moneo, V., Renner, O., et al. (2003) · Revista de Oncología · doi:10.1007/bf02711481 · Cited by 9
Cellular Senescence as a Target in Cancer Control
Carnero, A. (2007) · Current Cancer Therapy Reviews · doi:10.2174/157339407780126629 · Cited by 6
Gray‐Schopfer, V. C., & Bennett, D. C. (2006) · Wiley eBooks · doi:10.1002/9780470987100.ch24 · Cited by 6
Halaban, R., & Moellmann, G. E. (2006) · Wiley eBooks · doi:10.1002/9780470987100.ch22 · Cited by 5
Brandl, C., Kaesbauer, J., Weber, B. H. F., & Morsczeck, C. O. (2010) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00686.x · Cited by 4
Cancer of mice and men: old twists and new tails
van der Weyden, L., & Adams, D. J. (2013) · The Journal of Pathology · doi:10.1002/path.4184 · Cited by 4
Effect of Chemotherapy on the Tumor Microenvironment and Anti-tumor Immunity
Meniawy, T. M., Nowak, A. K., & Lake, R. (2012) · Springer eBooks · doi:10.1007/978-94-007-4694-7_1 · Cited by 4
Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53
Fry, E. A., Niehans, G. E., Kratzke, R. A., Kai, F., & Inoue, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217971 · Cited by 4
Zhang, F., Wang, Y., Wang, Y., Wang, X., Zhang, D., Zhao, X. Y., Jiang, R., Gu, Y., Yang, G., Fu, X., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4401 · Cited by 6
HDAC Inhibitors: An Emerging Anticancer Therapeutic Strategy
Kwon, P. O., Hsu, M., Cohen, D., & Atadja, P. W. (2006) · Humana Press eBooks · doi:10.1385/1-59745-024-3:315 · Cited by 4
Cell cycle control factors and skeletal development
Ogasawara, T. (2013) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2013.03.001 · Cited by 5
Cell Cycle Checkpoints and Senescence
Wadhwa, R., Kaul, Z., & Kaul, S. C. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_9 · Cited by 6
Mammalian Development and Cancer: A Brief History of Mice Lacking D-Type Cyclins or CDK4/CDK6
Kalaszczyńska, I., & Ciemerych, M. A. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_2 · Cited by 4
Sung, Y. H., Park, J., Choi, B., Kim, J., Cheong, C., Choi, Y. S., Yang, E. Y., Lee, M. J., Han, J., Park, S. C., et al. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.01.007 · Cited by 5
Selecting the Right Targets for Cancer Therapy
Bronchud, M. H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_1 · Cited by 6
Early diagnosis of melanoma: what do we know?
Yee, E., Hoffman, R. M., & Berwick, M. (2007) · Cited by 4
Quelle, D. E., Nteeba, J., & Darbro, B. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30060-8 · Cited by 6
The Role of Endothelin 3 in Melanoma Progression and Metastasis
Chin, N. L. (2015) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc000185 · Cited by 3
Senescent cell heterogeneity: origins, detection, and therapeutic implications
Wu, R., Zhu, J., Kim, H., & Xu, M. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.03.015 · Cited by 7
p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms
Moll, U. M., & Concin, N. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_6 · Cited by 4
A Comparison of Senescence in Mouse and Human Cells
Gorbunova, V. A., & Seluanov, A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1075-2_7 · Cited by 2
Ashmawey, A. M., Mohamed, W., Abdelsalam, I. M., El‐Gendy, S. M., Ali, A. I., & El-Aaser, A. A. (2011) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v2i1.3542 · Cited by 3
Teramoto, N., Ikeda, M., Sugihara, H., Shiga, T., Matsuwaki, T., Nishihara, M., Uchida, K., & Yamanouchi, K. (2021) · Journal of Veterinary Medical Science · doi:10.1292/jvms.21-0243 · Cited by 6
The Pt(S-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo
Silconi, Ž. B., Rosic, V., Benazic, S., Radosavljevic, G. D., Mijajlović, M. Ž., Pantic, J. M., Ratković, Z., Radić, G. P., Arsenijević, A., Milovanović, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158161 · Cited by 3
p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer
Bai, F., Liu, X., Zhang, X., Mao, Z., Wen, H., Ma, J., & Pei, X. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2225938 · Cited by 3
Wyles, S. P., Vyas, K. S., Wasserburg, J. R., Ansaf, R. B., & Kirkland, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00009-8 · Cited by 4
Senolytic Phytocompounds in Redox Signaling
Thirumurugan, K. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-84965-8_12 · Cited by 3
Kotake, Y., & Kitagawa, M. (2015) · Springer eBooks · doi:10.1007/978-4-431-55576-6_10 · Cited by 4
Regulation of cell cycle progression in astrocytes
Nakatsuji, Y., & Miller, R. H. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31003-3 · Cited by 3
Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
Malumbres, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_10 · Cited by 5
Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development
Wangari‐Talbot, J., Goydos, J. S., & Chen, S. (2010) · Pharmaceuticals · doi:10.3390/ph3092821 · Cited by 4
Induction of Histiocytic Sarcoma in Mouse Skeletal Muscle
Liu, J., Hettmer, S., Milsom, M. D., Hofmann, I., Hua, F., Miller, C. M., Bronson, R. T., & Wagers, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044044 · Cited by 3
Genetically Modified Animal Models
Chaible, L. M., Kinoshita, D., Corat, M. A. F., & Dagli, M. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00033-6 · Cited by 3
Noë, M., Hackeng, W. M., de Leng, W. W. J., Vergeer, M., Vleggaar, F. P., Morsink, F. H. M., Wood, L. D., Hruban, R. H., Offerhaus, G. J. A., & Brosens, L. A. A. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001314 · Cited by 5
Cellular Senescence and Tumor Promotion
Demaria, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_79 · Cited by 4
Molecular genetics of acute lymphoblastic leukemia
Mullighan, C. G. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.008 · Cited by 4
Glioma Oncogenesis and Animal Models of Glioma Formation
Lyustikman, Y., & Lassman, A. B. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.09.005 · Cited by 3
Schubert, N. A., van Hooff, S. R., Schild, L. G., Ober, K., Hortensius, M., van den Handel, K., Essing, A. H. W., Koopmans, B., Boeije, M., Proost, N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.27.465137 · Cited by 4
Hakim, S. G., von der Gracht, A., Pries, R., Rades, D., & Steller, D. (2023) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2023.06.008 · Cited by 2
Li, B., Chen, L., Su, Y., Meng, J., & Su, Z. (2026) · Biogerontology · doi:10.1007/s10522-026-10390-8 · Cited by 2
The ARF protein in tumor suppression: lessons from mouse models and human tumors
Rodríguez, I. P. (2004) · Clinical & Translational Oncology · doi:10.1007/bf02710031 · Cited by 2
21: Cancer and ageing: Rival demons?
Campisi, J. (2014) · European Journal of Cancer · doi:10.1016/s0959-8049(14)50021-4 · Cited by 2
Biologic Therapies in Orthopaedic Surgery
Su, C. A., Vopat, M. L., Jildeh, T. R., Day, H. K., Philippon, M. J., & Huard, J. (2022) · Operative Techniques in Orthopaedics · doi:10.1016/j.oto.2022.100963 · Cited by 2
Micheli, L., D’Andrea, G., Creanza, T. M., Volpe, D., Ancona, N., Scardigli, R., & Tirone, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1270892 · Cited by 2
Ohnuma, S., Tanaka, J., Yukimori, A., Ishida, S., Yasuhara, R., & Mishima, K. (2023) · Journal of Oral Biosciences · doi:10.1016/j.job.2023.12.002 · Cited by 4
Regulation of Cellular Senescence by the Retinoblastoma Pathway
Becker, T. M., & Rizos, H. (2003) · Springer eBooks · doi:10.1007/978-94-017-0669-8_9 · Cited by 2
Hematopoietic Stem Cells and Somatic Stem Cells
Tan, K. Y., Kim, F. S., Wagers, A. J., & Mayack, S. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-347-3_3 · Cited by 2
Mitotic regulation of CDK4 by the serine/threonine phosphatase, calcineurin
Chow, R. S., Olesen, J. D., Onyskiw, C., & Baksh, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.197 · Cited by 2
Greenwood, E. (2001) · Nature reviews. Cancer · doi:10.1038/35106018 · Cited by 2
Kawai, K., Li, Y., Song, M.-F., Ootsuyama, Y., Kakehashi, A., Wanibuchi, H., Ootsuyama, A., Norimura, T., & Kasai, H. (2012) · Genes and Environment · doi:10.3123/jemsge.34.123 · Cited by 3
Genetic and Molecular Pathology of Melanoma
Piepkorn, M. W. (2014) · Springer eBooks · doi:10.1007/978-3-642-38385-4_3 · Cited by 2
Transforming Growth Factor‐β and Cancer
Zhu, B., & Kyprianou, N. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap13.pub2 · Cited by 2
Jacobson, E., Toms, C., Huang, C. C., Skelton, H. G., & Smith, K. J. (2005) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.02215.x · Cited by 2
Metadata
- Authors
- Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6851
- Pages
- 86-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2017235640
- Cited by
- 848
- References
- 30
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 19 · 2023: 26 · 2022: 15 · 2021: 36 · 2020: 17 · 2019: 17 · 2018: 17 · 2017: 26 · 2016: 17 · 2015: 29 · 2014: 32 · 2013: 34 · 2012: 34
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p16INK4a, p19ARF, tumour suppressor, senescence, carcinogenesis, knockout mice, thymic hyperplasia, T cell proliferation, Ras-induced senescence, cell immortalization, carcinogen-induced cancer, p53
- MeSH terms
- Animals, Carcinogens, Cell Division, Cell Transformation, Neoplastic, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Male, Neoplasms, Proteins, T-Lymphocytes, Thymus Gland, Urethane, 9,10-Dimethyl-1,2-benzanthracene, Gene Deletion, Mice, Knockout, Gene Targeting, Genes, p16, Genetic Predisposition to Disease, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.